QTTBQ32 Bio Inc.同业对比
Q32 Bio Inc. 与Pharmaceutical Preparations的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 (Pharmaceutical Preparations)| 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| QTTB本股 | $262M#4 | 5.6x#1 | 5.6x#8 | 4.9x#4 | — | 162.5%#1 | 31.5%#1 | 64.3%#1 | — | — | 641.8%#1 | — |
| ALXO | $266M#2 | — | 1.8x#6 | — | — | 24.6%#7 | — | -67.2%#11 | -81.5%#1 | — | 282.8%#3 | — |
| ELDN | $262M#3 | — | 5.9x#9 | — | — | -26.1%#10 | — | -101.9%#12 | — | — | 0.7%#8 | — |
| TTRX | $252M#5 | — | 41.2x#14 | — | — | -80.6%#14 | — | -52.2%#10 | -560.9%#2 | — | — | — |
| MGNX | $234M#6 | — | 11.0x#12 | 1.6x#2 | -0.3%#4 | -11.4%#9 | -48.7%#4 | -0.4%#5 | — | — | 132.5%#5 | — |
| SIGA | $234M#7 | 11.7x#2 | 1.5x#4 | 2.5x#3 | -31.8%#5 | -60.7%#12 | 25.1%#3 | 15.4%#3 | — | — | -40.1%#13 | 18.4%#1 |
| CAPR | $225M#9 | — | 0.8x#2 | — | -100.0%#8 | -159.6%#15 | — | -37.7%#8 | — | — | -50.8%#14 | — |
| RNAC | $227M#8 | — | — | 567.4x#8 | -99.0%#7 | -68.3%#13 | -35851.3%#8 | — | — | — | -37.9%#12 | — |
| CAMP | $211M#10 | — | 6.8x#10 | 60.3x#7 | 436.5%#3 | -55.2%#11 | -1502.4%#6 | -260.2%#13 | — | — | 157.0%#4 | — |
| SCYX | $378M#1 | — | 9.2x#11 | 18.4x#5 | 449.9%#2 | 59.6%#4 | -78.0%#5 | -20.8%#7 | — | 5#1 | -12.7%#9 | — |
| GALT | $201M#11 | — | — | — | — | 34.5%#5 | — | — | — | — | -16.8%#10 | — |
| GLSI | $196M#16 | — | 37.1x#13 | — | — | -11.2%#8 | — | -367.3%#14 | — | — | 18.7%#7 | — |
| ANTX | $198M#12 | — | 2.4x#7 | — | — | 31.5%#6 | — | -43.0%#9 | — | — | 419.3%#2 | — |
| RNA | $197M#15 | — | 0.8x#3 | — | — | — | — | 0.0%#4 | — | — | -68.0%#15 | — |
| KROS | $198M#13 | — | 0.7x#1 | 0.8x#1 | 6775.0%#1 | 146.4%#2 | 27.7%#2 | 30.5%#2 | — | — | -30.1%#11 | — |
| WHWK | $197M#14 | — | 1.7x#5 | 27.5x#6 | -72.5%#6 | 67.7%#3 | -1601.1%#7 | -17.7%#6 | — | — | 126.1%#6 | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 数据构建于 2026-08-03。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议